Fidelity Investments
SLS icon

Fidelity Investments’s SELLAS Life Sciences SLS Stock Holding History

Fidelity Investments’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$377K Buy
25,533
+9,972
+64% +$68.8K ﹤0.01% 3401
2026
Q1 		$65.8K Buy
15,561
+8,066
+108% +$36.1K ﹤0.01% 3989
2025
Q4 		$28.3K Buy
7,495
+6,467
+629% +$12.6K ﹤0.01% 4332
2025
Q3 		$1.66K Buy
+1,028
New +$1.83K ﹤0.01% 4955
2025
Q1 		– Sell
-1
Closed -$1 – 5648
2024
Q4 		$1 Sell
1
-186
-99% -$212 ﹤0.01% 5515
2024
Q3 		$233 Buy
+187
New +$229 ﹤0.01% 5025
2024
Q2 		– Sell
-1
Closed -$1 – 5609
2024
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 5335
2021
Q4 		– Sell
-96
Closed -$1K – 4874
2021
Q3 		$1K Buy
+96
New +$891 ﹤0.01% 4197

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Fidelity Investments's SLS Position: Q2 2026 in Review

Fidelity Investments increased its SELLAS Life Sciences (SLS) stake by 64% in Q2 2026, buying an estimated $68.8K and bringing the position to 25,533 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #3401.

Fidelity Investments first reported a position in SLS in Q3 2021 and has held it in 8 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Fidelity Investments held 25,533 shares of SELLAS Life Sciences worth $377K as of Q2 2026.
  • Fidelity Investments bought 9,972 SELLAS Life Sciences shares in Q2 2026, an estimated $68.8K.
  • SELLAS Life Sciences made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3401 holding.
  • Fidelity Investments first reported a position in SELLAS Life Sciences in Q3 2021 and has held it in 8 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.